# Query Results

**Query:** financial statement key performance indicators

**Timestamp:** 20251020_025834

**Top K:** 5

**Results Found:** 5

---

## Result 1

**Similarity Score:** 0.3942 | **Semantic:** 0.5632 | **Keyword:** 0.0000 | **Rerank:** 0.7140

**Source:** ibaion-beam-applications-iobcf-revenue-breakdown-main-composition-futubull.md

**Chunk ID:** 31

**Content:**

```
](https://www.futunn.com/en/stock/IOBCF-US/financials-key-indicators)[Income Statement](https://www.futunn.com/en/stock/IOBCF-US/financials-income-statement)[Balance Sheet](https://www.futunn.com/en/stock/IOBCF-US/financials-balance-sheet)[Cash Flow](https://www.futunn.com/en/stock/IOBCF-US/financials-cash-flow)
# IBA(ION BEAM APPLICATIONS) (IOBCF) Revenue Breakdown Overview
### By Business/Source
Currency:EUR 
2024/FY 
2024/FY 
2023/FY 
2022/FY 
2021/FY 
2020/FY 
2019/FY 
Stock NameRevenueRati
```

---

## Result 2

**Similarity Score:** 0.4056 | **Semantic:** 0.5705 | **Keyword:** 0.0208 | **Rerank:** 0.5227

**Source:** martiniai.md

**Chunk ID:** 25

**Content:**

```
upporting ongoing investments and debt servicing. The equity-to-assets ratio further underscores a solid equity base 1. Considering these financial indicators, IBA demonstrates a healthy financial state characterized by steady revenue growth, profitability, liquidity, manageable leverage, operational efficiency, and strong cash flow generation. While specific credit ratings and beta values are not detailed in the provided sources, the overall financial performance suggests stability and a low de
```

---

## Result 3

**Similarity Score:** 0.3631 | **Semantic:** 0.5186 | **Keyword:** 0.0000 | **Rerank:** -6.9972

**Source:** martiniai.md

**Chunk ID:** 22

**Content:**

```
y equity market performance and inflation trends. Continuous monitoring of these factors is essential for a comprehensive assessment of IBA's credit risk. ### Financial Summary
Ion Beam Applications (IBA), a Belgium-based company in the Health Care sector, exhibits a financially sound profile based on its 2024 performance 1. The company's stable total revenue growth highlights its strong position in the irradiation and electromedical equipment manufacturing market.
```

---

## Result 4

**Similarity Score:** 0.3719 | **Semantic:** 0.5313 | **Keyword:** 0.0000 | **Rerank:** -7.0057

**Source:** ion-beam-applications-sa-iba-deiob-stock-statistics-valuation-metrics-tiprankscom.md

**Chunk ID:** 53

**Content:**

```
Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses.
```

---

## Result 5

**Similarity Score:** 0.3623 | **Semantic:** 0.5175 | **Keyword:** 0.0000 | **Rerank:** -7.1130

**Source:** martiniai.md

**Chunk ID:** 58

**Content:**

```
d on current macro environment up till mid-2025]. Overall, IBA's macro-driven credit profile appears to be moderately influenced by broader economic conditions, with equity market performance and inflation trends being key factors to monitor. Thus monitoring these two macro factors will be essential since they materially influence borrowing costs, cost structures, and ultimately financial stability metrics underpinning corporate debt ratings within health care tech subsectors.
```

---

